Gaithersburg’s Novavax Inc. is on the cusp of rolling out its Covid-19 vaccine to the public. But first, a Centers for Disease Control and Prevention advisory panel must review the biotech’s protein-based vaccine. That’s on the calendar for Tuesday, less than a week after the Food and Drug Administration authorized the product for emergency use in the U.S.
Novavax’s Covid vaccine up for review by CDC advisory committee
July 19, 2022
